One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Monthly Production Capacity: 1000kg
Packaging Information: 25kg/drum 1kg/bottle
Delivery Lead Time: 7 days after payment
Sample Provided: yes
Payment Terms: L/L
Product Information
Product name
Valsartan
CAS No.
137862-53-4
Molecular Formula
C24H29N5O3
Molecular Weight
435.519
Quality Standard
98% up, USP/JP/EP
Appearance
White to almost white powder
COA of Valsartan
ITEMS
STANDARDS
RESULTS
Appearance
White to almost white powder
White powder
Identification
Infrared absorption:
The IR spectrum is consistent with that obtained with the reference
Conforms
The retention time of the major peak in the chromatogram of the assay preparation corresponds to that in the chromatogram of the standard preparation, as obtained in the assay
Conforms
Absorbance
NMT 0.02
0.003
Water
NMT2.0%
0.56%
Residue on ignition
NMT0.1%
0.06%
Heavy metals
NMT0.001%
Related compounds
(HPLC)
Compound A NMT1.0%
0.49%
Compound B NMT0.2%
0.08%
Compound C NMT0.1%
Undetected
Any other individual impurity NMT0.1% (excluding compound A )
0.04%
Total impurities NMT0.3% (excluding compound A )
0.20%
Residual solvents(GC)
Ethyl acetate NMT5000ppm
2820ppm
Dichloromethane NMT600ppm
Undetected
Methanol NMT3000ppm
Undetected
N,N-Dimethylformamide NMT880ppm
Undetected
Assay
98.0—102.0%
99.2%
Conclusion
The analysis results show that this batch of valsartan conforms to USP
Usage
Function of Valsartan
Valsartan is an angiotensin II receptor antagonist anti-hypertensive drug. The drug can block the type I (AT1) receptor of angiotensin II, increase the plasma level of angiotensin II and stimulate The unblocked AT2 receptor also counteracts the role of the AT1 receptor, so as to achieve the effect of dilating blood vessels and lowering blood pressure, the effect is lasting and stable, and the toxic and side effects are small. Therefore, valsartan is mainly suitable for antihypertensive, mild to moderate primary hypertension, especially for the treatment of secondary hypertension caused by kidney damage.
Twenty years of qualification
Audited Supplier
Pharma Sources Insight January 2025
